Identification of In Vivo–Expressed Antigens ofStaphylococcus aureusand Their Use in Vaccinations for Protection against Nasal Carriage

Citations Over TimeTop 10% of 2006 papers

Abstract

A spectrum of in vivo-expressed Staphylococcus aureus antigens was identified by probing bacteriophage expression libraries of S. aureus with serum samples from infected and uninfected individuals. Eleven recombinant antigenic proteins were produced, and specific antibody titers in a large collection of human serum samples were determined. Significantly increased concentrations of reactive immunoglobulin G (IgG) to 7 antigens were found in serum samples from ill individuals, compared with those in healthy individuals. Significantly higher concentrations of reactive IgG to 4 antigens, including iron-responsive surface determinant (Isd) A and IsdH, were found in serum samples from healthy individuals who were not nasal carriers of S. aureus, compared with those in healthy carriers. Vaccination of cotton rats with IsdA or IsdH protected against nasal carriage. Also, IsdA is involved in adherence of S. aureus to human desquamated nasal epithelial cells and is required for nasal colonization in the cotton rat model. Thus, vaccination with these antigens may prevent S. aureus carriage and reduce the prevalence of human disease.

Related Papers

• → Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model(2005)183 cited
• → Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice(2015)9 cited
• → Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus(1981)34 cited
• → Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis(1987)18 cited
• → Two forms of Staphylococcus aureus in blood of patients with staphylococcal sepsis(1979)6 cited